Drug Database
Back to search

United States· US:43598-230_1afa82f5-9ea2-5d75-688e-a44a867bd377

Colesevelam Hydrochloride

A colesevelam product containing colesevelam hydrochloride, registered in United States by Dr.Reddys Laboratories Inc. The same ATC class is registered in 14 of our 19 countries.

ATC C10AC04US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedColesevelam HydrochlorideATCC10AC04REGISTER NO.US:43598-230_1afa82f5…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about colesevelam hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Colesevelam is registered in 14 of 19 countries.

Countries holding a registration under ATC C10AC04 (colesevelam), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose
Search colesevelam products by name

Colesevelam · ATC C10AC04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of colesevelam costs, country by country.

Normalised to the WHO defined daily dose (3.75 g), the median price runs from $1.57 in United States to $5.96 in Spain — a ×3.8 gap.

  • United States: $1.57 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Colesevelam · price per daily dose (3.75 g)

USD · FX 28 Sept 2026

  • ES Spain$5.96
  • US United States$1.57 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
COLESEVELAM HYDROCHLORIDE
Manufacturer
Dr.Reddys Laboratories Inc
Country
United States (US)
ATC code
C10AC04
ATC class
Colesevelam
Defined daily dose
3.75 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    43598-230-18
  • ndc11
    4359823018
    180 TABLET in 1 BOTTLE (43598-230-18)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

63 interactions on record for colesevelam.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check colesevelam against other medicinesHow interaction checks work

Colesevelam · interactions on record

63 records

  • 5 severe
  • 58 moderate

Most severe, free to view

  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe
  • Mycophenolic acidL04AA06severe
  • TeriflunomidL04AA31severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Colesevelam in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All colesevelam products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Germany · Colesevelamhydrochlorid Ascend
  • United Kingdom (Northern Ireland) · Colesevelam Hydrochloride Consilient Health, Colesevelam Hydrochloride Dr. Reddy's Laboratories (Uk)
  • Iceland · Cholestagel
  • Liechtenstein · Cholestagel
  • Norway · Cholestagel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/debab78d-aac5-4999-8b80-1eb4a751aa7c
GET /v1/drugs/debab78d-aac5-4999-8b80-1eb4a751aa7c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "625",
  "substance": "COLESEVELAM HYDROCHLORIDE",
  "productndc": "43598-230",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA210889",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about colesevelam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console